They usually start with high doses and then lower them for maintenance
Read safety information Supporting research A selection of peer-reviewed work on AOD 9604/MOTS-C
It aids in the production of melatonin, which regulates sleep and wake cycles, as well as serotonin, which influences deep sleep and wakefulness
GLP-1 receptor agonists such as Saxenda and Wegovy work, with clinical trial evidence behind them roughly 6% and 16% body weight reduction respectively over 68-week trials
The peptide should be administered on an empty stomach when possible, as food intake may affect absorption and blunt the acute lipolytic effects
Its effects stay focused on adipose tissue: AOD9604 stimulates lipolysis primarily through beta3 adrenergic receptor pathways in adipose tissue, driving the breakdown of stored triglycerides into free fatty acids